Biomea Fusion, Inc. Company Profile
Biomea Fusion, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 1599 INDUSTRIAL ROAD, SAN CARLOS, California, 94070, United States.
- Mailing address: Value 1599 INDUSTRIAL ROAD, SAN CARLOS, California, 94070, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 1599 INDUSTRIAL ROAD, SAN CARLOS, California, 94070, United States |
| Mailing address | 1599 INDUSTRIAL ROAD, SAN CARLOS, California, 94070, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | <br>Emerging growth company |
| Listed stock (Section 12(b)) | Common Stock, $0.0001 par value · BMEA · The Nasdaq Global Select Market 10-Q filed 2026-08-05 cover |
| Shell company | No 10-Q filed 2026-08-05 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-05 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-05 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-05 cover |
| Well-known seasoned issuer | No 10-K filed 2026-03-24 cover |
| Voluntary filer | No 10-K filed 2026-03-24 cover |
| First EDGAR filing | 2021-01-15 (D) |
| SEC CIK | 1840439 |
| EIN | 000000000 |
| Phone | (650) 980-9099 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |